Lianya Pharmaceuticals' ChiNext IPO has been approved, and 12 products including sustained-release metoprolol succinate tablets have been approved by the NMPA for listing and sale.

According to the intelligent financial APP, on July 9th, Nantong Lianya Pharmaceutical Co., Ltd. (referred to as Lianya Pharmaceutical) has passed the listing committee meeting of the ChiNext board of the Shenzhen Stock Exchange for its IPO. China International Finance Co., Ltd. is its sponsor and it plans to raise 950 million yuan.